Washington University Conducts Trial to Assess Breakthrough Stem Cell Production Technology

Washington University Conducts Trial to Assess Breakthrough Stem Cell Production Technology

The FDA has given the green light to a first-ever clinical trial to assess the ApoGraft technology for haploidentical bone marrow transplantations to be conducted at Washington University School of Medicine in St. Louis. Sponsor is Cellect Biotechnology Ltd., (NASDAQ:...
Cellular Therapy Research Trials Should Consider Centers with FACT Accreditation

Cellular Therapy Research Trials Should Consider Centers with FACT Accreditation

Cell therapy (part of regenerative medicine) continues to attract attention as biopharmaceutical sponsors invest heavily in cell-therapy-driven pipelines, invest in manufacturing capacity and war for talent. Just in the first half of 2019, cell-based ventures raised...

Pin It on Pinterest